Anti-CD33 Chimeric Antigen Receptor Therapy For Acute Myeloid Leukemia

被引：1
|
作者：
O'Hear, Carol E.
Heiber, Joshua
Geiger, Terrence L.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1441.1441
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1441
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Role of Anti-CD33 for the Treatment of Acute Myeloid Leukemia - Systematic Review and Meta-Analysis
    Gurion, Ronit
    Gafter-Gvili, Anat
    Ram, Ron
    Vidal, Liat
    Raanani, Pia
    Shpilberg, Ofer
    BLOOD, 2012, 120 (21)
  • [32] Affinity tuning anti-CD123 chimeric antigen receptor natural killer cell therapy to treat acute myeloid leukemia
    Kizerwetter, Monika
    Yang, Huilin
    Rahnama, Ruyan
    Bonifant, Challice
    Spangler, Jamie
    CANCER RESEARCH, 2024, 84 (06)
  • [33] Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
    Boucher, Justin C.
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Leick, Mark
    Cervantes, Estelle V.
    Ghafoor, Tayyebb
    Reid, Kayla
    Spitler, Kristen
    Yu, Bin
    Betts, Brian C.
    Guevara-Patino, Jose A.
    Maus, Marcela V.
    Davila, Marco L.
    MOLECULAR THERAPY ONCOLYTICS, 2023, 31
  • [34] Bispecific CD33/CD123 Targeted Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia
    Boucher, Justin C.
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Leick, Mark B.
    Nhan Tu
    Ghafoor, Tayyebb
    Reid, Kayla M.
    Spitler, Kristen
    Yu, Bin
    Maus, Marcela, V
    Davila, Marco L.
    BLOOD, 2022, 140 : 10275 - 10276
  • [35] Chimeric Antigen Receptor (CAR) T Cell Therapy for CD7-Positive Acute Myeloid Leukemia
    Gomes-Silva, Diogo
    Tashiro, Haruko
    Srinivasan, Madhuwanti
    Lulla, Premal
    Brenner, Malcolm K.
    Mamonkin, Maksim
    BLOOD, 2017, 130
  • [36] Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemia
    Stasi, Roberto
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (04) : 527 - 540
  • [37] An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker
    Hamann, PR
    Hinman, LM
    Beyer, CF
    Lindh, D
    Upeslacis, J
    Flowers, DA
    Bernstein, I
    BIOCONJUGATE CHEMISTRY, 2002, 13 (01) : 40 - 46
  • [38] Development of a 89Zr radiolabeled anti-CD33 antibody for PET imaging of Acute Myeloid Leukemia
    Buckway, Brandon
    Burrell, Lance
    Shami, Paul
    Kosak, Ken
    Lum, David
    Yap, Jeffrey
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] Bismuth-labeled anti-CD33 antibody for elimination of minimal residual disease in acute myeloid leukemia
    Mulford, D
    Chaitanya, D
    McDevitt, M
    Sgouros, G
    Finn, R
    Larson, S
    Apostolidis, C
    Morgenstern, A
    Scheinberg, D
    Jurcic, J
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (04) : 526 - 526
  • [40] Chimeric Antigen Receptor for Specific Targeting of Acute Myeloid Leukemia
    Pizzitola, Irene
    Anjos-Afonso, Fernando
    Rouault-Pierre, Kevin
    Lassailly, Francois
    Tettamanti, Sarah
    Biondi, Andrea
    Biagi, Ettore
    Bonnet, Dominique
    BLOOD, 2012, 120 (21)
12345